Buscar
Mostrando ítems 1-10 de 548
Analysis of Availability and Access of Anti-myeloma Drugs and Impact on the Management of Multiple Myeloma in Latin American Countries
(Elsevier Inc., 2019)
© 2018 Elsevier Inc. Latin American countries represents a large fraction of patients who are treated for multiple myeloma in the world and difficulties of access to new agents and real-world practice are important issues. ...
Multiple myeloma with cells typically seen in storage diseases
(Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular, 2011-02-01)
We report on a rare case of multiple myeloma with atypically large cells containing a great amount of azurophilic inclusions usually seen in storage diseases.
Pathologic mandibular fracture as first sign of multiple myeloma
(2016-03-23)
Multiple myeloma (MM) is a neoplasia characterized by the proliferation of plasmacytoid cells, which produce abnormal immunoglobulins. It frequently creates local and systemic complications such as pathologic fractures and ...
PLASMA PREKALLIKREIN, COAGULATION AND FIBRINOLYTIC PARAMETERS IN MYELOMA PATIENTS
(Springer VerlagNew York, 1992)
The increased expression of receptor activator of nuclear-κB ligand (RANKL) of multiple myeloma bone marrow stromal cells is inhibited by the bisphosphonate ibandronate
(2010)
The receptor activator of nuclear factor-kappaB ligand (RANKL) and interleukin-1beta are osteoclast activating factors which are abnormally expressed in bone marrow stromal cells and plasma cells of multiple myeloma patients. ...
Understanding myeloma cancer stem cells
(Future Medicine Ltd, 2013-12-01)
Plasmablastic multiple myeloma is associated with increased vascular endothelial growth factor immunoexpression
(Associação Brasileira de Divulgação Científica, 2005-11-01)
The biologic basis of the negative prognosis of plasmablastic myeloma is not fully understood. To determine whether histologically aggressive multiple myeloma (MM) is associated with a more angiogenic marrow environment, ...